Intimation of schedule of Investor Meet on Friday, September 04, 2026

Emcure Ref: EPL/CS/SE/0079/2026 Date: September 01, 2026 National Stock Exchange of India Limited BSE Limited Exchange Plaza, C-1, Block G, P J Towers, Bandra Kurla Complex, Bandra (East), Dalal Street, Mumbai – 400 051 Mumbai- 400 001 Script Symbol: EMCURE Scrip Code/Symbol: 544210/ EMCURE Dear Sir/Madam, Subject: Intimation of schedule of Analyst/ Investor Meeting(s) Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find below proposed schedule of participation in Investor Meet by Officials of the Company: Day & Date Analysts/ Investor / Event City Mode Friday, September 04, 2026 Meeting with group of P u n e Physical Institutional Investors The schedule is tentative, and changes may happen due to exigencies on the part of Investors/Company. No unpublished price sensitive information is proposed to be shared / discussed with aforesaid analyst/ investors during the meeting. You are requested to take the above information on your records. Thanking you, For Emcure Pharmaceuticals Limited Amruta Yangalwar Company Secretary & Compliance Officer ICSI Membership Number: A25687 Emcure Pharmaceuticals Limited Registered Office: Plot No. P-1 & P-2, IT-BT Park, Phase-II, M.I.D.C., Hinjawadi, Pune - 411057, Maharashtra, India Phone Nos.: +91 20 – 35070033/ 35070000 Fax No.: +91 20 3507 0060 E-mail: corporate@emcure.com Website: www.emcure.com CIN: L24231PN1981PLC024251